beta-lapachone has been researched along with Obesity in 2 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pharmacological activation of NADH oxidation by NQO1 resolves obesity and related phenotypes in mice, opening the possibility that it may provide the basis for a new therapy for the treatment of metabolic syndrome." | 7.75 | Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice. ( Choi, HS; Chung, J; Han, J; Hwang, JH; Jang, C; Jo, EJ; Jo, YS; Kho, YL; Kim, DW; Kim, JM; Kim, YK; Kwak, TH; Kweon, GR; Kyung, T; Lee, I; Lee, SH; Park, JH; Park, MK; Shong, M; Yoo, SK, 2009) |
| "Pharmacological activation of NADH oxidation by NQO1 resolves obesity and related phenotypes in mice, opening the possibility that it may provide the basis for a new therapy for the treatment of metabolic syndrome." | 3.75 | Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice. ( Choi, HS; Chung, J; Han, J; Hwang, JH; Jang, C; Jo, EJ; Jo, YS; Kho, YL; Kim, DW; Kim, JM; Kim, YK; Kwak, TH; Kweon, GR; Kyung, T; Lee, I; Lee, SH; Park, JH; Park, MK; Shong, M; Yoo, SK, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, WH | 1 |
| Ahn, J | 1 |
| Jung, CH | 1 |
| Jang, YJ | 1 |
| Ha, TY | 1 |
| Hwang, JH | 1 |
| Kim, DW | 1 |
| Jo, EJ | 1 |
| Kim, YK | 1 |
| Jo, YS | 1 |
| Park, JH | 1 |
| Yoo, SK | 1 |
| Park, MK | 1 |
| Kwak, TH | 1 |
| Kho, YL | 1 |
| Han, J | 1 |
| Choi, HS | 1 |
| Lee, SH | 1 |
| Kim, JM | 1 |
| Lee, I | 1 |
| Kyung, T | 1 |
| Jang, C | 1 |
| Chung, J | 1 |
| Kweon, GR | 1 |
| Shong, M | 1 |
2 other studies available for beta-lapachone and Obesity
| Article | Year |
|---|---|
β-Lapachone Prevents Diet-Induced Obesity by Increasing Energy Expenditure and Stimulating the Browning of White Adipose Tissue via Downregulation of miR-382 Expression.
Topics: Adipocytes; Adipocytes, Brown; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Calorimetry, I | 2016 |
Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice.
Topics: Adenylate Kinase; Animals; Disease Models, Animal; Energy Metabolism; Metabolic Syndrome; Mice; Mice | 2009 |